Aegerion Pharmaceuticals, Inc. Announces Presentation at the 31st Annual J.P. Morgan Healthcare Conference
Published: Jan 03, 2013
CAMBRIDGE, Mass., Jan. 3, 2013 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat debilitating and often fatal rare diseases, announced today that the company will participate in the 31st Annual J.P. Morgan Healthcare Conference in San Francisco. Marc Beer, CEO of Aegerion, is scheduled to present on Tuesday, January 8, 2013 at 2:00 pm PT (5:00 pm ET).